Custom Search

Saturday, September 29, 2012

Defibrillator S ICD System without wires placed inside heart vein

US FDA approves novel defibrillation device which don’t require its wire ( lead ) to be inserted in to heart vein

Cardiac arrests are major causes for loss of lives around the globe. In case of sudden cardiac arrest or cardiac arrhythmia, stimuli of lower intensity electric impulse can save lives, bringing back heart to normal functioning this is also known as defibrillation therapy.

Some patients with arrhythmia are susceptible for sudden arrest and cardiac arrhythmia therefore there is great need for devices which provide a stimuli (defibrillation therapy) as and when in situation of crisis of cardiac arrhythmia. These devices are placed surgically in to patients body with one or two wires (leads ) of these devices directly entering in to vein supplying blood to heart (transvenou leads) .

In some patients these wires (leads) may cause complications like fibrosis in areas of direct contact with vein and heart tissue vasculature and myocardium over the period of time damaging heart vasculature and heart tissue.

Cameron Health Inc have developed a Subcutaneous Implantable Defibrillator (S-ICD) System which do not require its wires(lead) to be implanted in to veins , instead it is just require subcutaneous implantation with its electrod placed parallel to the left sternal border, and do not require any surgical procedure involving patient’s blood vessels or heart. This device detect any abnormal heart activity and provides electric impulse to heart.

The device is equally effective as regular defibrillator implants. This device will be helpful for patients who suffer from complications with transvenous lead.

There are some contraindications for the device as well which are symptomatic bradycardia, incessant ventricular tachycardia.

Also see
What is an artificial pacemaker device ?

New drug to reduce risk of formation of blood clot after hip  knee replacement surgery.

First Pacemaker which can work safely during MRI scanning approved by US FDA

New treatment discovered for making kidney transplant successful.

New analog of antibiotic vancomycine which even work in case bacteria develop and activate antibiotic resistance

Insuline now provides hope for treatment of Alzheimer’s disease

New drug for treatment of atypical Hemolytic Uremic Syndrome (aHUS)

Why water for pharmaceutical use is always kept in close loop in continuous circulation?

No comments:

How to successfuly activate and receive our articles on pharmaceuticals by E-Mail

Dear readers if you wish to receive our articles on pharmaceutical automatically into your email Inbox , as and when we write a new article over this website, then follow these 3 simple steps.

1.You should write your Email ID in the box provided and push the subscribe button

2.Enter the text code that we show you in a small new browser window after you enter your email ID.

3.Log in to your email and Check our verification email sent by "FEEDBURNER" , there you should verify the link we send you by email.

Enter your email address get our articles by email whenever this website is updated

Delivered by FeedBurner

Join the list of our readers from Universities ,Research and
Development centers Pharmaceutical Companies from all over the world.

Pharma Research Regulatory Guidelines Website
Texas Dallas, TX 75211 US
Email: Website:
Copyright © 2008-2020 all rights reserve